​COVID-19​ (​​Coronavirus): Update to AIM guidelines to allow CT for diagnosis of COVID-19 pneumonia​​​​

May 12, 2020

This article was revised on May 12, 2020, to reflect the updated policy name.

AmeriHealth is committed to providing our members with access to the care they need. As COVID-19 has escalated into a pandemic, we are working to make sure that our members can receive appropriate testing and treatment for the virus causing COVID-19 if needed.

We encourage all AmeriHealth members to visit our dedicated AmeriHealth New Jersey and AmeriHealth Pennsylvania COVID-19 webpages regularly for the latest news and updates. We will continue to evaluate member needs as the situation changes.

Changes to AIM guidelines

Effective March 12, 2020, AIM Specialty Health® (AIM) has revised their Clinical Appropriateness Guidelines for Advanced Imaging – Appropriate Use Criteria: Imaging of the Chest. The revised guidelines are available on AIM's website.

The summary changes to the Guideline are as follows:

  • Chest imaging:
    • Allow CT for diagnosis of COVID-19 pneumonia

Advanced imaging of the chest is considered medically necessary for individuals under investigation, as defined by the Centers for Disease Control and Prevention (CDC), for Coronavirus Disease 2019 (COVID-19) pneumonia when reverse transcription polymerase chain reaction (RT-PCR) is negative or cannot be performed.

You can view the complete announcement, Computed tomography (CT) chest imaging for diagnosis of COVID-19 pneumonia, on our Medical Policy Portal in the News & Announcements section.

Learn more

For more information about the AmeriHealth position on COVID-19, please review the following resources: